International Collaboration to Fund Innovative Research into CAR T-cell Therapy and Paediatric Leukaemia

Snowdome is very proud to continue our collaboration with the prestigious Leukemia & Lymphoma Society USA and Australia’s Leukaemia Foundation to fund Australian researchers and clinicians specialising in blood cancer research. Now entering our fourth year of funding, we are delighted to announce funding for two more ground-breaking projects into treating paediatric leukaemia and CAR … Continued

Six marathons in four days, in honour of a mother lost to blood cancer

Alastair Evans set out to honour his mother, Sally, aiming to raise $75,000 for blood cancer research, through a fundraising event called The Positive Journey – a four-day 270km run from Melbourne to Echuca, his hometown. Joining with friends, family and donors, Alastair raised over $150,000, running the equivalent of six marathons. The funds raised … Continued

The Wilson family donate a further $3.5 million to provide blood cancer patients with life saving genomic testing

The Wilson family has extended their generous philanthropic donation to the Snowdome Foundation, providing an additional $3.5 million for the Wilson Centre for Blood Cancer Genomics housed at the Peter MacCallum Cancer Centre.    This is the philanthropic family’s second major gift. In 2017, The Wilsons announced a major gift of $5.5 million to establish the Centre. The Wilson family have now donated more than $9 million to the Snowdome … Continued

New treatment for Waldenström’s macroglobulinemia approved by the TGA and offered free of charge to patients

Zanubrutinib is a new small molecule inhibitor of Bruton tyrosine kinase (BTK) that has been compared to ibrutinib in clinical trials.  The ASPEN trial compared zanubrutinib to ibrutinib for the treatment of patient with Waldenström’s macroglobulinemia (WM) and demonstrated a higher very good partial response rate as well as improvements in safety and tolerability.  The … Continued